These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37354643)

  • 1. Trends in the incidence, prevalence and sales volume of menopausal hormone therapy in Sweden from 2000 to 2021.
    Sundell M; Brynhildsen J; Spetz Holm AC; Fredrikson M; Hoffmann M
    Maturitas; 2023 Sep; 175():107787. PubMed ID: 37354643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of menopausal hormone therapy use in Korea (2002-2013): A nationwide cohort study.
    Park CY; Lim JY; Kim WH; Kim SY; Park HY
    Maturitas; 2021 Apr; 146():57-62. PubMed ID: 33722365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
    Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016.
    Heinig M; Braitmaier M; Haug U
    Pharmacoepidemiol Drug Saf; 2021 Apr; 30(4):462-471. PubMed ID: 33368726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.
    Antoine C; Ameye L; Paesmans M; de Azambuja E; Rozenberg S
    Maturitas; 2016 Feb; 84():81-8. PubMed ID: 26654400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case-control study in Sweden.
    Dehara M; Kullberg S; Bixo M; Sachs MC; Grunewald J; Arkema EV
    Eur J Epidemiol; 2024 Mar; 39(3):313-322. PubMed ID: 38212490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insufficient use of menopausal hormone therapy in Swedish women with early or premature menopause caused by bilateral oophorectomy: a register-based study.
    Sundell M; Brynhildsen J; Fredrikson M; Hoffmann M; Spetz Holm AC
    BJOG; 2024 Mar; 131(4):500-507. PubMed ID: 37667667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
    Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
    Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
    Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.
    Velentzis LS; Banks E; Sitas F; Salagame U; Tan EH; Canfell K
    PLoS One; 2016; 11(3):e0146494. PubMed ID: 27008039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and breast cancer incidence in Korean women.
    Choi E; Lee JK; Baek JK; Chung Y; Kim H; Yun BH; Seo SK
    Maturitas; 2024 May; 183():107946. PubMed ID: 38412593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging.
    Câmara SMA; Macêdo PRS; Velez MP
    Menopause; 2023 Mar; 30(3):254-259. PubMed ID: 36729434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and recent evolution of menopausal hormone therapy use in a cohort of Swedish women.
    Fournier A; Weiderpass E
    Climacteric; 2009 Oct; 12(5):410-8. PubMed ID: 19415542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What the Women's Health Initiative has taught us about menopausal hormone therapy.
    Chester RC; Kling JM; Manson JE
    Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormonal therapy in surgically menopausal women with underlying endometriosis.
    Tanmahasamut P; Rattanachaiyanont M; Techatraisak K; Indhavivadhana S; Wongwananuruk T; Chantrapanichkul P
    Climacteric; 2022 Aug; 25(4):388-394. PubMed ID: 34783284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior pre-eclampsia does not diminish the vascular protective effect of menopausal hormone therapy.
    Venetkoski M; Savolainen-Peltonen H; Joensuu JM; Gissler M; Ylikorkala O; Mikkola TS
    Maturitas; 2024 Nov; 189():108112. PubMed ID: 39244940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
    Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
    Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.